Sodium butyrate and short chain fatty acids in prevention of travellers' diarrhoea: A randomized prospective study

Travel Medicine and Infectious Disease

Volumn 12, Issue 2, 2014, Pages 183-188

  Krokowicz, Lukasz ^a   Kaczmarek, Bartosz F ^b   Krokowicz, Piotr ^a   Stojcev, Zoran ^c,d   Mackiewicz, Jacek ^a,e,f   Walkowiak, Jaroslaw ^a   Drews, Michal ^a   Banasiewicz, Tomasz ^a,g  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Holy Family Hospital   (Poland)

^c Regional Specialist Hospital   (Poland)

^d MEDICAL UNIVERSITY OF GDANSK   (Poland)

^e GREATER POLAND CANCER CENTRE   (Poland)

^f Malgorzata Medical Center   (Poland)

^g NZOZ Center for Medical Genetics   (Poland)

Author keywords

Short chain fatty acids; Sodium butyrate; Travellers' diarrhoea

Indexed keywords

BUTYRIC ACID; CITRIC ACID; FUMARIC ACID; MALIC ACID; PLACEBO; SORBIC ACID; TRIACYLGLYCEROL; VOLATILE FATTY ACID;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADULT; ARTICLE; BLOATING; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; NAUSEA; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TRAVELLER DIARRHEA; TROPICS; VOMITING; DIARRHEA; EMPORIATRICS; TRAVEL;

BUTYRIC ACID; DIARRHEA; FATTY ACIDS, VOLATILE; HUMANS; QUESTIONNAIRES; TRAVEL; TRAVEL MEDICINE;

EID: 84898599406     PISSN: 14778939     EISSN: 18730442     Source Type: Journal    
DOI: 10.1016/j.tmaid.2013.08.008     Document Type: Article

References (33)

1. R.E. Black Epidemiology of travelers' diarrhea and relative importance of various pathogens Rev Infect Dis 12 Suppl. 1 1990 S73 S79 [Epub 1990/01/01]
2. Is prophylaxis of travelers' diarrhea recommended? 2006 CDC Website [January 31st, 2013]; Available from: http://www.cdc.gov/ncidod/dbmd/ diseaseinfo/travelersdiarrhea-g.htm
3. R.E. Black Pathogens that cause travelers' diarrhea in Latin America and Africa Rev Infect Dis 8 Suppl. 2 1986 S131 S135 [Epub 1986/05/01]
4. H.L. DuPont Systematic review: prevention of travellers' diarrhoea Aliment Pharmacol Ther 27 9 2008 741 751 [Epub 2008/02/21]
5. H.L. DuPont, C.D. Ericsson, P.C. Johnson, J.A. Bitsura, M.W. DuPont, and F.J. de la Cabada Prevention of travelers' diarrhea by the tablet formulation of bismuth subsalicylate JAMA J Am Med Assoc 257 10 1987 1347 1350 [Epub 1987/03/13]
6. E. Hilton, P. Kolakowski, C. Singer, and M. Smith Efficacy of Lactobacillus GG as a diarrheal preventive in travelers J Travel Med 4 1 1997 41 43 [Epub 1997/03/01]
7. H.L. DuPont, Z.D. Jiang, P.C. Okhuysen, C.D. Ericsson, F.J. de la Cabada, and S. Ke et al. A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea Ann Intern Med 142 10 2005 805 812 [Epub 2005/05/18]
8. C.M. Rademaker, I.M. Hoepelman, M.J. Wolfhagen, H. Beumer, M. Rozenberg-Arska, and J. Verhoef Results of a double-blind placebo-controlled study using ciprofloxacin for prevention of travelers' diarrhea Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 8 8 1989 690 694 [Epub 1989/08/01]
9. A. Wagner, and U. Wiedermann Travellers' diarrhoea - pros and cons of different prophylactic measures Wien Klin Wochenschr 121 Suppl. 3 2009 13 18 [Epub 2009/12/29]
10. T. Banasiewicz, L. Krokowicz, Z. Stojcev, B.F. Kaczmarek, E. Kaczmarek, and J. Maik et al. Microencapsulated sodium butyrate reduces the frequency of abdominal pain in patients with irritable bowel syndrome Colorectal Dis 15 2 2013 204 209
11. S. Cordel, B. Dupas, J.Y. Douillard, and K. Meflah Interleukin-2/sodium butyrate treatment cures rats bearing liver tumors after acquired 5-fluorouracil resistance Int J Cancer 78 6 1998 735 739
12. J.F. Hall, P.L. Roberts, R. Ricciardi, T. Read, C. Scheirey, and C. Wald et al. Long-term follow-up after an initial episode of diverticulitis: what are the predictors of recurrence? Dis Colon Rectum 54 3 2011 283 288
13. P. Vernia, V. Annese, G. Bresci, G. d'Albasio, R. D'Inca, and S. Giaccari et al. Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial Eur J Clin Invest 33 3 2003 244 248
14. H.M. Hamer, D. Jonkers, K. Venema, S. Vanhoutvin, F.J. Troost, and R.J. Brummer Review article: the role of butyrate on colonic function Aliment Pharmacol Ther 27 2 2008 104 119 [Epub 2007/11/02]
15. D.L. Topping, and P.M. Clifton Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides Physiol Rev 81 3 2001 1031 1064 [Epub 2001/06/28]
16. D.R. Hill Occurrence and self-treatment of diarrhea in a large cohort of Americans traveling to developing countries Am J Trop Med Hyg 62 5 2000 585 589 [Epub 2001/04/06]
17. J. Yates Traveler's diarrhea Am Fam Physician 71 11 2005 2095 2100 [Epub 2005/06/15]
18. S. Alajbegovic, J.W. Sanders, D.E. Atherly, and M.S. Riddle Effectiveness of rifaximin and fluoroquinolones in preventing travelers' diarrhea (TD): a systematic review and meta-analysis System Rev 1 1 2012 39 [Epub 2012/08/30]
19. J.D. Fuller, and D.E. Low A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance Clin Infect Dis Off Publ Infect Dis Soc Am 41 1 2005 118 121 [Epub 2005/06/07]
20. J. Tack Antibiotic therapy for the irritable bowel syndrome N Engl J Med 364 1 2011 81 82 [Epub 2011/01/07]
21. T. Valentin, E. Leitner, A. Rohn, I. Zollner-Schwetz, M. Hoenigl, and H.J. Salzer et al. Rifaximin intake leads to emergence of rifampin-resistant staphylococci J Infect 62 1 2011 Jan 34 38 [Epub 2010 Nov 10]
22. E.J. Bow Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients Curr Opin Infect Dis 24 6 2011 Dec 545 553
23. M.F. Gordon, R.I. Abrams, D.B. Rubin, W.B. Barr, and D.D. Correa Bismuth subsalicylate toxicity as a cause of prolonged encephalopathy with myoclonus Mov Disord Off J Mov Disord Soc 10 2 1995 220 222 [Epub 1995/03/01]
24. M. Teepker, H.M. Hamer, S. Knake, O. Bandmann, W.H. Oertel, and F. Rosenow Myoclonic encephalopathy caused by chronic bismuth abuse Epileptic Disord Int Epilepsy J Videotape 4 4 2002 229 233 [Epub 2003/02/26]
25. P. Hruz, M. Mayr, R. Low, J. Drewe, and G. Huber Fanconi's syndrome, acute renal failure, and tonsil ulcerations after colloidal bismuth subcitrate intoxication Am J Kidney Dis Off J Natl Kidney Found 39 3 2002 E18 [Epub 2002/03/06]
26. P.C. Mendelowitz, R.S. Hoffman, and S. Weber Bismuth absorption and myoclonic encephalopathy during bismuth subsalicylate therapy Ann Intern Med 112 2 1990 140 141 [Epub 1990/01/15]
27. R. Lopez-Gigosos, P. Garcia-Fortea, M.J. Calvo, E. Reina, R. Diez-Diaz, and E. Plaza Effectiveness and economic analysis of the whole cell/recombinant B subunit (WC/rbs) inactivated oral cholera vaccine in the prevention of traveller's diarrhoea BMC Infect Dis 9 2009 65 [Epub 2009/05/19]
28. T. Jelinek, and H. Kollaritsch Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera Expert Rev Vaccines 7 5 2008 561 567 [Epub 2008/06/20]
29. R.B. Canani, G. Terrin, P. Cirillo, G. Castaldo, F. Salvatore, and G. Cardillo et al. Butyrate as an effective treatment of congenital chloride diarrhea Gastroenterology 127 2 2004 630 634 [Epub 2004/08/10]
30. M.G. Schmitt Jr., K.H. Soergel, and C.M. Wood Absorption of short chain fatty acids from the human jejunum Gastroenterology 70 2 1976 211 215 [Epub 1976/02/11]
31. W.E. Roediger Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man Gut 21 9 1980 793 798 [Epub 1980/09/01]
32. J.M. Wong, R. de Souza, C.W. Kendall, A. Emam, and D.J. Jenkins Colonic health: fermentation and short chain fatty acids J Clin Gastroenterol 40 3 2006 235 243 [Epub 2006/04/25]
33. P. Perrin, E. Cassagnau, C. Burg, Y. Patry, F. Vavasseur, and J. Harb et al. An interleukin 2/sodium butyrate combination as immunotherapy for rat colon cancer peritoneal carcinomatosis Gastroenterology 107 6 1994 1697 1708 [Epub 1994/12/01]